Alcon (ALC) Long-Term Deferred Tax (2009 - 2026)
Alcon (ALC) posted quarterly Long-Term Deferred Tax of $464.0 million for Q1 2026, up 979.07% year-on-year from $43.0 million in Q1 2025, and up 1.31% on a QoQ basis from $458.0 million in Q4 2025.
Alcon (ALC) Long-Term Deferred Tax (2009 - 2026) Analysis & Trends
Alcon (ALC) has reported Long-Term Deferred Tax for 11 consecutive years, with $464.0 million the latest figure, recorded in Q1 2026.
- Quarterly Long-Term Deferred Tax rose 979.07% year-over-year to $464.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $464.0 million (up 979.07% YoY) and the FY2025 annual result came in at $458.0 million, up 8.79% from the prior year.
- Long-Term Deferred Tax advanced to $464.0 million in Q1 2026 per ALC's latest filing, from $458.0 million in the prior quarter.
- Over the last five years, Long-Term Deferred Tax for ALC reached as high as $1.3 billion in Q4 2022 and fell as low as $43.0 million in Q1 2025.
- A 5-year average of $466.9 million and a median of $441.0 million in 2024 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2025 — Long-Term Deferred Tax tumbled 90.25% — and 2026, when it soared 979.07%.
- Year by year, Long-Term Deferred Tax stood at $1.3 billion in 2022, then slumped by 66.92% to $443.0 million in 2023, then fell by 4.97% to $421.0 million in 2024, then climbed by 8.79% to $458.0 million in 2025, then grew by 1.31% to $464.0 million in 2026.
- According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $464.0 million, $458.0 million, and $477.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 464.00 Mn |
| Dec 31, 2025 | 458.00 Mn |
| Sep 30, 2025 | 477.00 Mn |
| Jun 30, 2025 | 470.00 Mn |
| Mar 24, 2025 | 43.00 Mn |
| Dec 31, 2024 | 421.00 Mn |
| Sep 30, 2024 | 458.00 Mn |
| Jun 30, 2024 | 448.00 Mn |
| Mar 31, 2024 | 441.00 Mn |
| Dec 31, 2023 | 443.00 Mn |
| Sep 30, 2023 | 414.00 Mn |
| Jun 30, 2023 | 406.00 Mn |
| Mar 31, 2023 | 421.00 Mn |
| Dec 31, 2022 | 1.34 Bn |
| Sep 30, 2022 | 413.00 Mn |
| Jun 30, 2022 | 409.00 Mn |
| Mar 31, 2022 | 413.00 Mn |
| Dec 31, 2021 | 1.16 Bn |
| Sep 30, 2021 | 418.00 Mn |
| Jun 30, 2021 | 401.00 Mn |